microdosing semaglutide menopause HRT and Weight Loss Study Findings for Menopausal Women Microdosing GLP-1s: A New Approach

Visceral fatthe metabolically active fat surrounding internal organsis strongly associated with cardiovascular disease, type 2 diabetes, and metabolic syndrome

Improvements in the understanding of the complex pathogenesis of T2D has resulted in the development of several new-generation glucose-lowering agents with complementary mechanisms of action, which have expanded treatment options and management strategies for patients with T2D

I went from [a HbA1c of] 47 to 35

Not every patient wants the most potent medication

Zinc is essential for protein metabolism, ammonia detoxification, immune function, and taste regulation

Int J Mol Sci 20(17):4092 Meier JJ (2012) GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus